CTI BIOPHARMA CORP Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CTI BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CTI BIOPHARMA CORP for January 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Sell | S | 1.20 | 10,000 | 12,012 | 2,248,302 | 2.3 M to 2.2 M (-0.44 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.20 | 2,600 | 3,120 | 1,054,992 | 1.1 M to 1.1 M (-0.25 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.20 | 300 | 359 | 1,057,592 | 1.1 M to 1.1 M (-0.03 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.19 | 1,800 | 2,142 | 1,057,892 | 1.1 M to 1.1 M (-0.17 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.19 | 2,000 | 2,370 | 1,059,692 | 1.1 M to 1.1 M (-0.19 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.18 | 2,500 | 2,950 | 1,061,692 | 1.1 M to 1.1 M (-0.23 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.18 | 700 | 823 | 1,064,192 | 1.1 M to 1.1 M (-0.07 %) |
Jan 29 2016 | CTIC | CTI BIOPHARMA CORP | SINGER JACK W | EVP, Chief Scientif ... | Sell | S | 1.17 | 5,100 | 5,967 | 1,064,892 | 1.1 M to 1.1 M (-0.48 %) |
Jan 13 2016 | CTIC | CTI BIOPHARMA CORP | PERRY MATTHEW D | Director | Option Exercise | A | 0.00 | 84,034 | 0 | 84,034 | |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 58,613 | 71,338 | 17,263,200 | 17.2 M to 17.3 M (+0.34 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 32,571 | 39,642 | 3,090,744 | 3.1 M to 3.1 M (+1.07 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 90,049 | 109,599 | 8,850,836 | 8.8 M to 8.9 M (+1.03 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 186,314 | 226,763 | 15,592,160 | 15.4 M to 15.6 M (+1.21 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 8,091 | 9,848 | 17,204,587 | 17.2 M to 17.2 M (+0.05 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 29,655 | 36,093 | 3,058,173 | 3 M to 3.1 M (+0.98 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 87,747 | 106,797 | 8,760,787 | 8.7 M to 8.8 M (+1.01 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 508,287 | 618,636 | 15,405,846 | 14.9 M to 15.4 M (+3.41 %) |
Jan 08 2016 | CTIC | CTI BIOPHARMA CORP | BIANCO JAMES A | President and CEO | Option Exercise | A | 1.20 | 2,700,000 | 3,240,000 | 2,700,000 | |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.26 | 200 | 252 | 610,084 | 610.3 K to 610.1 K (-0.03 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.25 | 600 | 750 | 610,284 | 610.9 K to 610.3 K (-0.10 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.24 | 202 | 250 | 610,884 | 611.1 K to 610.9 K (-0.03 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.24 | 300 | 371 | 611,086 | 611.4 K to 611.1 K (-0.05 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.23 | 800 | 984 | 611,386 | 612.2 K to 611.4 K (-0.13 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.22 | 1,700 | 2,074 | 612,186 | 613.9 K to 612.2 K (-0.28 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.21 | 1,900 | 2,299 | 613,886 | 615.8 K to 613.9 K (-0.31 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.21 | 800 | 964 | 615,786 | 616.6 K to 615.8 K (-0.13 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.20 | 1,898 | 2,278 | 616,586 | 618.5 K to 616.6 K (-0.31 %) |
Jan 06 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 1.20 | 1,600 | 1,912 | 618,484 | 620.1 K to 618.5 K (-0.26 %) |